Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference40 articles.
1. Current concepts in the Management of Muscle Invasive Bladder Cancer;Krishna;Indian J. Surg. Oncol.,2017
2. Molecular mechanisms of cisplatin resistance;Galluzzi;Oncogene,2012
3. Urothelial and kidney cancers, cancer management;Hurwitz;Oncology,2016
4. gp130: a promising drug target for cancer therapy;Xu;Expert Opin. Ther. Targets,2013
5. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy;Selander;Cancer Res.,2004
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Emerging Role of Natural Products in Cancer Treatment;Archives of Toxicology;2024-05-25
2. The use of curcumin in the treatment of colorectal, breast, lung, and prostate cancers: An in vivo study update;Journal of Lab Animal Research;2023-12-25
3. Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines;International Journal of Molecular Sciences;2022-09-20
4. Serum IL-6 level is associated with clinical outcome of intravesical gemcitabine therapy in T1 non-muscle–invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2022-09
5. Synergistic induction of IL-6 production in human bronchial epithelial cells in vitro by nickel nanoparticles and lipopolysaccharide is mediated by STAT3 and C/EBPβ;Toxicology in Vitro;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3